Symfi™ (efavirenz/lamivudine/tenofovir disoproxil fumarate) – New drug approval
March 22, 2018 - The FDA approved Mylan’s Symfi (efavirenz [EFV]/lamivudine [3TC]/tenofovir disoproxil fumarate [TDF]) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adult and pediatric patients weighing ≥ 40 kg.
Top